FNY Managed Accounts’s AngioDynamics ANGO Stock Holding History

FNY Managed Accounts’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$0	Sell	10 -317	-97%	-$5.29K	﹤0.01%	606
2017 Q4	$5K	Sell	327 -981	-75%	-$16.7K	﹤0.01%	304
2017 Q3	$22K	Buy	+1,308	New	+$22K	0.03%	321

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

FNY Managed Accounts's ANGO Position: Q1 2018 in Review

FNY Managed Accounts reduced its AngioDynamics (ANGO) stake by 97% in Q1 2018, selling an estimated $5.29K and leaving 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #606.

FNY Managed Accounts first reported a position in ANGO in Q3 2017 and has held it in 3 quarters since. The position peaked at $22K in Q3 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.

FNY Managed Accounts held 10 shares of AngioDynamics worth $0 as of Q1 2018.
FNY Managed Accounts sold 317 AngioDynamics shares in Q1 2018, an estimated $5.29K.
AngioDynamics made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #606 holding.
FNY Managed Accounts first reported a position in AngioDynamics in Q3 2017 and has held it in 3 quarters since.
FNY Managed Accounts's AngioDynamics position peaked at $22K in Q3 2017.
164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.